These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5035396)

  • 1. [Clinical test of the therapeutic effectiveness of hepatic opotherapy associated with high doses of nucleosides].
    Vercillo L; Mollica G; Florio G
    Minerva Med; 1972 Jun; 63(44):2478-85. PubMed ID: 5035396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical research on the hepatoprotective and antianemic action of hepatic opotherapy associated with nucleosides in high doses].
    Bestagno M
    Arch Maragliano Patol Clin; 1966; 22(3):299-309. PubMed ID: 5953073
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic activity in the geriatric age of hepatic opotherapy in association with high doses of nucleosides].
    Baldoni E; Floris E; Serenthà P; Negri U; Nuzzo L
    G Gerontol; 1968 Nov; 16(11):1261-99. PubMed ID: 5731973
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled clinico-statistical studies on the role of the nucleosides in an association of hepatoprotective and anti-asthenic action].
    Soranzo ML
    Minerva Med; 1974 Feb; 65(8):391-7. PubMed ID: 4820721
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of liver-protective agents containing cytidine and uridine in the therapy of patients with liver diseases].
    Grimaldi N; Santoro C
    Policlinico Med; 1971; 78(3):134-46. PubMed ID: 5568445
    [No Abstract]   [Full Text] [Related]  

  • 6. [Considerations on the treatment with the combination of ribonucleosides, hepatic extract and vitamin B-12 (Nuclepatox) of acute and chronic liver diseases in the course of pulmonary tuberculosis].
    Ravazzoni C; Balzano E; Cuneo S
    Minerva Med; 1967 Jan; 58(6):141-7. PubMed ID: 6016918
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adrenocortical extract, liver extract and nucleosides as metabolism-stimulating antianemic and liver protecting agents].
    Tolva D
    Minerva Med; 1973 Dec; 64(89):4692-7. PubMed ID: 4775168
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nucleosides in the therapy of hepatopathies].
    Urbinati GC
    Clin Ter; 1966 Oct; 39(1):39-54. PubMed ID: 5998856
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the use of liver extracts enriched with uridine, cytidine and vitamin B 12 in pediatric therapy].
    Rizzo A
    Minerva Pediatr; 1971 May; 23(18):803-10. PubMed ID: 5090393
    [No Abstract]   [Full Text] [Related]  

  • 10. [Exepin in pediatric practice].
    Russo U; Romoli F
    Minerva Pediatr; 1971 May; 23(18):811-5. PubMed ID: 5090394
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatotropic and proteo-anabolic therapeutic effects of a total hepatic preparation with a constant titer of natural coenzymatic cobalamin].
    Guidetti E; Vacha R; Vacha G
    Clin Ter; 1969 May; 49(4):323-36. PubMed ID: 5795020
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of treatment with nucleosides, liver extract and vitamin B 12 on various hepatic functional defects and on cellular proliferation of bone marrow in chronic liver diseases].
    Turpini R
    Clin Ter; 1970 Apr; 53(1):9-23. PubMed ID: 5472849
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases].
    Pignattari S; Sarti F; Toscano S; Dal Monte PR
    Minerva Med; 1972 Jul; 63(53):2861-72. PubMed ID: 5049878
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of a new hepatoprotective drug on bilirubinemia in geriatric age patients].
    Baldoni E; Floris E; Nuzzo L
    G Gerontol; 1968 Aug; 16(8):789-92. PubMed ID: 5740954
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cholesterolemic changes after treatment with a new hepatoprotective drug in geriatric patients].
    Baldoni E; Floris E; Nuzzo L
    G Gerontol; 1968 Aug; 16(8):785-7. PubMed ID: 5740953
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled clinical trial of a liver extract combined with high doses of nucleosides, cobamamide and adrenal cortex extract in the treatment of acute liver diseases].
    Resta M; Vitali D; Medina F
    Clin Ter; 1972 Aug; 62(3):213-23. PubMed ID: 4562915
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of alcoholic liver disease: studies of 10 cases].
    Silvi G; Stellato S
    Clin Ter; 1978 Feb; 84(3):275-82. PubMed ID: 639480
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled evaluation of the clinical effects of an association of hepatic extract, adrenal cortex extract, vitamin B 12 and vitamins of B complex].
    Scacciante L; Gianfranceschi G; Bertelletti D
    Clin Ter; 1974 Aug; 70(3):259-72. PubMed ID: 4609267
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alphamercaptopropionylglycine in chronic hepatopathies].
    Cacciari G; Malaguti P; Zincati GC
    Policlinico Med; 1972; 79(3):165-73. PubMed ID: 5051108
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medivitan, an addition to our therapeutic possibilities].
    Grebe H
    Dtsch Med J; 1969 Jan; 20(2):74-7. PubMed ID: 5785577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.